Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

March 2017 Issue of The Ophthalmologist

Welcome to March’s issue. Upfront’s topics range from infant cataract surgery to a myopia cell, and In My View sees Harry Quigley make the case for better measures of doctors’ success. Our Features take an in-depth look at what could be refractive surgery’s Holy Grail – eyedrops for presbyopia and explore the quest to develop non-invasive biomechanical assessments of the eye, and shares opinions from leading experts in the field. In Practice introduces a new surgical technique for advanced keratoconus, and NextGen features an overview of bone marrow stem cells for retinal disorders. In Profession, two experts discuss what healthcare changes under Trump might mean for ophthalmology. Finally, we Sit Down With Mark Baum and Martine Jager.

Register to download

Register here to download any issue of The Ophthalmologist for FREE.

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

Articles featured in this issue

Business & Profession Health Economics and Policy

An Issue of Inequity

| Mark Hillen

Poorer people suffer poorer outcomes across all of medicine. Can eyecare buck the trend?

Subspecialties Refractive

Ctrl + Shift + IOL

| Roisin McGuigan

Controlling for myopic shift following cataract surgery in infants: too many variables?

Business & Profession Other

It’s Good to Talk

| Roisin McGuigan

What patients report versus what physicians record can be substantially different…

Subspecialties Basic & Translational Research

ON Delayed Gratification

| Ruth Steer

Could a newly identified retinal ganglion cell type unlock the mystery of myopia?

Business & Profession Business and Innovation

Business in Brief

| Ruth Steer

JNJ completes AMO purchase, new CMO for Glaukos and more…

Subspecialties Retina

Peptide Power

| Ruth Steer

Could a small biomimetic peptide be a promising alternative to anti-VEGF treatment?

Subspecialties Cataract

Rupture Risk

| Ruth Steer

Mounting evidence suggests intravitreal injections increase risk of PCR during cataract surgery – why?

Business & Profession Basic & Translational Research

Image of the Month

Using an audio interpretive tool to create artwork by, and for, the visually impaired.

Business & Profession Health Economics and Policy

How Good a Doctor Are You?

| Harry Quigley

Your income may depend on it… but we have no real way to measure what actually matters to patients.

Subspecialties Retina

A-peeling Approach?

| Dante Pieramici

ILM peeling for macular holes - not always necessary or without risk.

Business & Profession Basic & Translational Research

Refractive Surgery's Holy Grail…

| Shafi Balal

Eyedrops for presbyopia.

Subspecialties Cornea / Ocular Surface

Bowman + Bulk = Better Results

| Mohammad Khan

Mid-stromal lamellar keratoplasty (MSLK) is a new surgical technique for advanced keratoconus.

Subspecialties Retina

It’s in Their Bones

| Elad Moisseiev and Susanna Park

Bone marrow stem cells for the treatment of retinal disease are closer than you might think.

Subspecialties Basic & Translational Research

Benchmarking Dry AMD

| Roisin McGuigan

What does analysis of the last five years of dry AMD literature tell us about the field?

Business & Profession Professional Development

From Obamacare to Trumpcare

| Alan Reider, Allison Shuren, Candy Simerson

The future of healthcare remains uncertain – what are the potential outcomes for ophthalmology?

Subspecialties Professional Development

Like Einstein, Question Everything

Advances aren’t made by following dogma, but by interrogating it.

Business & Profession Professional Development

An Arm and a Leg

| Mark Baum

Mark Baum, founder and CEO of Imprimis Pharmaceuticals.

Business & Profession Professional Development

Stop! Collaborate and Listen

Martine Jager, Professor, Leiden University Medical Centre, The Netherlands.

Business & Profession Cataract

Progressive Optics for Impressive Outcomes

The SIFI MiniWeLL IOL provides a progressive, extended depth-of-focus experience for patients.

Other issues of 2017